全文获取类型
收费全文 | 1443篇 |
免费 | 43篇 |
国内免费 | 75篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 50篇 |
妇产科学 | 39篇 |
基础医学 | 181篇 |
口腔科学 | 21篇 |
临床医学 | 159篇 |
内科学 | 330篇 |
皮肤病学 | 39篇 |
神经病学 | 84篇 |
特种医学 | 269篇 |
外科学 | 126篇 |
综合类 | 30篇 |
预防医学 | 57篇 |
眼科学 | 26篇 |
药学 | 75篇 |
中国医学 | 3篇 |
肿瘤学 | 64篇 |
出版年
2023年 | 7篇 |
2021年 | 16篇 |
2020年 | 11篇 |
2019年 | 12篇 |
2018年 | 17篇 |
2016年 | 14篇 |
2015年 | 20篇 |
2014年 | 22篇 |
2013年 | 27篇 |
2012年 | 32篇 |
2011年 | 32篇 |
2010年 | 44篇 |
2009年 | 60篇 |
2008年 | 35篇 |
2007年 | 65篇 |
2006年 | 43篇 |
2005年 | 51篇 |
2004年 | 29篇 |
2003年 | 29篇 |
2002年 | 25篇 |
2001年 | 38篇 |
2000年 | 42篇 |
1999年 | 24篇 |
1998年 | 90篇 |
1997年 | 72篇 |
1996年 | 69篇 |
1995年 | 54篇 |
1994年 | 46篇 |
1993年 | 49篇 |
1992年 | 28篇 |
1991年 | 25篇 |
1990年 | 30篇 |
1989年 | 41篇 |
1988年 | 46篇 |
1987年 | 32篇 |
1986年 | 29篇 |
1985年 | 32篇 |
1984年 | 21篇 |
1983年 | 20篇 |
1982年 | 22篇 |
1981年 | 11篇 |
1980年 | 19篇 |
1979年 | 10篇 |
1978年 | 15篇 |
1977年 | 21篇 |
1976年 | 16篇 |
1975年 | 18篇 |
1974年 | 6篇 |
1972年 | 6篇 |
1970年 | 6篇 |
排序方式: 共有1561条查询结果,搜索用时 15 毫秒
1.
P Avalos-Peralta† A Herrera† JJ Ríos-Martín‡ AM Pérez-Bernal† D Moreno-Ramírez† F Camacho† 《Journal of the European Academy of Dermatology and Venereology》2006,20(1):79-83
We report the case of a patient with a 13-year history of pemphigus vulgaris (PV) treated with immunosuppressive agents, prednisone and mycophenolate mofetil who had developed lesions of Kaposi's sarcoma (KS) on a sole plaque of PV that had been previously treated with intralesional injections of steroids. The lesions were surgically removed and polymerase chain reaction (PCR) demonstrated human herpesvirus-8 (HHV-8) DNA. There were neither recurrences nor later dissemination of KS following gradual decrease of the immunosuppressive therapy. We suggest that the treatment with intralesional steroids may have influenced the local reactivation of a latent infection of the virus, determining the appearance of this localized KS. 相似文献
2.
CM Reid M. Nelson P. Beckinsale P. Ryan LMH Wing LJ Beilin MA Brown GLR Jennings CI Johnston J. Marley JJ McNeil TO Morgan J. Shaw ID Steven MJ West 《Clinical and experimental pharmacology & physiology》1997,24(5):370-373
1. The present study aimed to determine the feasibility of conducting a 5 year cardiovascular outcome trial of the treatment of 6000 elderly hypertensive patients in Australian general practices. 2. General practitioners (GPs) were invited to participate by mail and personal follow-up. Patient records were reviewed to identify subjects for a blood pressure (BP) screening programme. Blood pressure was measured on three occasions and eligible subjects were included if the average BP was 160 mmHg systolic or 90 mmHg diastolic if systolic BP was 140 mmHg. 3. Seven hundred and forty-one GPs were approached and 89 were enrolled in the study (12% of mail invites and 75% of those receiving a personal contact). In 16 practices where screening was completed, 82 000 records were reviewed to identify 4% patients eligible for screening. Twenty-two per cent of eligible subjects attended screening. Of 1938 subjects screened, 180 (9%) had BP 5=160/90 mmHg. Forty-seven percent of subjects (n = 916) were receiving antihypertensive therapy and 184 (20%) were withdrawn from therapy. One hundred and sixteen (63%) of these subjects had BP return to study entry levels within 6 weeks. Fifty-seven newly diagnosed and 81 previously treated subjects were randomized (7% of the screened population). 4. Based on the high participation rate of GPs, the response rate of patients to attend a BP screening programme and the 7% randomization to screening ratio for entry into the study, the ANBP2 pilot study has demonstrated that it is feasible to recruit subjects from Australian general practices to a cardiovascular outcome trial. 相似文献
3.
4.
5.
6.
A M Glasgow J Weissberg-Benchell W D Tynan S F Epstein C Driscoll J Turek E Beliveau 《Pediatrics》1991,88(1):98-104
The characteristics of children with diabetes readmitted to Children's Hospital during a 5-year period, 1984 to 1989, were compared with those characteristics of new-onset patients admitted for stabilization and education and to outpatients in the Children's Hospital diabetes program to determine which characteristics were associated with patients who were readmitted. Changes in the frequency of readmissions were examined to determine whether the introduction of a diabetes team and a program that emphasizes the importance of ensuring that patients at risk of readmission consistently received insulin injections resulted in a reduction of readmissions. Readmissions occurred more frequently in patients who were black (71% compared with 38% of new-onset patients and 31% of outpatients) (P less than .001), from one-parent homes (56% compared with 27% of new-onset patients and 24% of outpatients) (P less than .001), and without third-party insurance (45% compared with 18% of new-onset patients and 15% of outpatients) (P less than .001). Readmissions were very common at 14 to 15 years of age (39% of readmissions vs 18% of outpatients) and very uncommon in children younger than age 9 (6% of readmissions vs 27% of outpatients) (P less than .001). Fewer readmissions for ketoacidosis occurred in the summer than in any other season (P less than .05). Readmissions fell by 47% over the 5-year period while new-onset patients increased by 85%. The reduction in frequency of readmissions was due to fewer readmissions for ketoacidosis and fewer readmissions in blacks, in patients from one-parent homes, and in patients without third-party insurance.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
7.
8.
SUMMARY A young patient presenting with splenomegaly and hypersplenism was inadvertently found to have selective IgA deficiency. There were no symptoms of immunodeficiency and the patient responded well to splenectomy, with return of blood counts to normal without adverse effects. No other cause for the hypersplenism was found. We postulate selective IgA deficiency as a cause of splenomegaly and hypersplenism. 相似文献
9.
10.
E.M. Smith Ph.D. S.R. Johnson M.D. E.J. Figuerres M.S. M. Mendoza M.S. D. Fedderson B.S. T.H. Haugen M.D. L.P. Turek M.D. 《Gynecologic oncology》1997,65(3):441-446
Postmenopausal women enrolled in the Iowa portion of the postmenopausal estrogen/progestin interventions randomized clinical trial (n= 105) during 1989–1991 were studied for (i) the prevalence of human papillomavirus (HPV) in this older age population (ages 45–64), and (ii) the association between hormone replacement therapies (HRTs) and changes in detection of HPV over a 2-year time period. HPV is causative in most cervical and some other genital cancers and in the presence of steroid hormones has been shown to increase neoplastic transformation by HPVin vitro.Using PCR to detect HPV DNA, the overall frequency of the virus regardless of time period was 50.3% (n= 53) with a baseline (BL) frequency of 38.1% and the second year follow-up (FU) of 22.9%. The oncogenic types HPV-16 (75.5%) and HPV-31 (20.8%) were the most commonly reported. All those with persistently detected infection (10.5%), defined as HPV+ at both BL and FU, were identified with HPV-16 or -18. Between these two time periods there were no significant differences in HPV frequency between the placebo and combined HRT groups (BL−/FU+, 21% vs 18%; BL+/FU−, 71% vs 80%). While the study is based on a small sample, the findings suggest that short-term use of HRTs is not associated with an increased risk of HPV detection, but assessment of effects from long-term use is needed. The data also indicate that the frequency of HPV found in older women is higher than previously suspected but that short-term changes in HPV detected in this age group are unrelated to the development of precancerous cervical lesions. 相似文献